Global Gastric Cancer Market Assessment, By Type [Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Others], By Stages [Stage I, Stage II, Stage III, Stage IV, Others], By Drug Class [PD-1/PD-L1 Inhibitors, HER2 Antagonists, VEGFR2 Antagonists, Others], By Diagnosis [Endoscopy, Biopsy, Imaging Tests, Exploratory Surgery, Others], By Treatment [Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Palliative Care, Others], By Route of Administration [Oral, Parenteral, Others], By Distribution Channel [Hospital Pharmacy, Online Pharmacy, Retail Pharmacy], By End-users [Hospitals, Homecare, Specialty Centers, Others], By Region, Opportunities and Forecast, 2017-2031F